Leonardo Roever: Exploring the Role of Glutamine Metabolism in Atherosclerosis
Leonardo Roever, CEO of Brazilian Evidence-Based Health Network, shared a post on LinkedIn about a recent article by Jiangqin Wang et al., published in Current Atherosclerosis Reports, adding:
“Glutamine Metabolism: A Metabolic Axis Connecting Vascular Remodeling and Plaque Stability in Atherosclerosis
Atherosclerosis (AS) – the pathological basis of atherosclerotic cardiovascular disease (ASCVD) – is a chronic, progressive inflammatory disease. Its major clinical events are primarily caused by plaque rupture and subsequent thrombosis.
Growing evidence suggests that metabolic reprogramming is a key regulator of vascular cell phenotypic transitions and plaque progression.
Among the various metabolic pathways, glutamine (Gln) metabolism is of particular interest because it links nutrient availability to vascular cell function – facilitating the supply of carbon and nitrogen, the maintenance of redox homeostasis, and the generation of metabolites involved in epigenetic regulation.
This review summarizes recent advances in Gln metabolism and discusses its regulatory roles in vascular remodeling and plaque stability, focusing on implications for AS pathogenesis and therapeutic strategies.”
Title: Glutamine Metabolism: a Metabolic Hub Linking Vascular Remodeling and Plaque Stability in Atherosclerosis
Authors: Jiangqin Wang, Jingwen Wang, Peng Gao, Jie Tian
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke